Skip to main content
Log in

Immuno-PCR Assay for Quantitation of Antibodies to Epstein–Barr Virus

  • Methods
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Successful disease prevention and therapy critically depend on timely diagnosis of infections. Quantitative immuno-PCR (qiPCR) technology improves the sensitivity in the detection of antibodies to pathogens. A qiPCR-based assay was developed to determine IgG antibodies to Epstein–Barr virus (EBV) in the human blood serum. EBV nuclear protein 1 fragment (pEBV) was expressed in Escherichia coli. A synthetic single-stranded deoxyribonucleotide was conjugated to streptavidin, and the conjugate was used to detect рEBV–IgG1–biotin complexes by qiPCR. The IgG1 titers determined by qiPCR were compared to the results of enzyme-linked immunosorbent assay (ELISA). The sensitivity of qiPCR was one order of magnitude higher than that of ELISA. Thus, a highly sensitive qiPCR-based assay was developed to quantitate antibodies specific to the recombinant EBV antigen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ELISA:

enzyme-linked immunosorbent assay

EBNA1:

Epstein–Barr nuclear antigen 1

EBV:

Epstein–Barr virus

IgG1:

immunoglobulin G1

iPCR:

immuno-PCR

qiPCR:

quantitative iPCR

sODN:

streptavidin–oligodeoxyribonucleotide complex

References

  1. Ryazantsev D.Y., Voronina D.V., Zavriev S.K. 2016. Immuno-PCR: Achievements and perspectives. Biochemistry (Moscow). 81, 1754–1770.

    PubMed  CAS  Google Scholar 

  2. Chang L., Li J., Wang L. 2016. Immuno-PCR: An ultrasensitive immunoassay for biomolecular detection. Anal. Chim. Acta. 910, 12–124.

    Article  PubMed  CAS  Google Scholar 

  3. Jani D., Savino E., Goyal J. 2015. Feasibility of immuno-PCR technology platforms as an ultrasensitive tool for the detection of anti-drug antibodies. Bioanalysis. 7, 285–294.

    Article  PubMed  CAS  Google Scholar 

  4. Mweene A.S., Ito T., Okazaki K., Ono E., Shimizu Y., Kida H. 1996. Development of immuno-PCR for diagnosis of bovine herpesvirus 1 infection. J. Clin. Microbiol. 34, 748–750.

    PubMed  PubMed Central  CAS  Google Scholar 

  5. Halpern M.D., Jain S., Jewett M.W. 2013. Enhanced detection of host response antibodies to Borrelia burgdorferi using immuno-PCR. Clin. Vaccine Immunol. 20, 350–357.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Spengler M., Adler M., Jonas A., Niemeyer C. 2009. Immuno-PCR assays for immunogenicity testing. Biochem. Biophys. Res. Commun. 387, 278–282.

    Article  PubMed  CAS  Google Scholar 

  7. Morin I., Askin S.P., Schaeffer P.M. 2011. IgG-detection devices for the Tus-Ter-lock immuno-PCR diagnostic platform. Analyst. 136, 4815–4821.

    Article  PubMed  CAS  Google Scholar 

  8. Chia-Ching L., Subramaniam S., Sivasubramanian S., Feng-Huei L. 2016. MWCNT-Fe3O4-based immuno- PCR for the early screening of nasopharyngeal carcinoma. Mater. Sci. Eng. C. Mater. Biol. Appl. 61, 422–428.

    Article  PubMed  CAS  Google Scholar 

  9. Singh N., Sreenivas V., Gupta K.B., Chaudhary A., Mittal A., Varma-Basil M., Prasad R., Gakhar S.K., Khuller G.K., Mehta P.K. 2015. Diagnosis of pulmonary and extrapulmonary tuberculosis based on detection of mycobacterial antigen 85B by immuno-PCR. Diagn. Microbiol. Infect. Dis. 83, 359–364.

    Article  PubMed  CAS  Google Scholar 

  10. Rymbai M.L., Ramalingam V.V., Samarasan I., Chandran B.S., Mathew G., Jerobin J., Abraham A.M., Sachithanandham J., Kannangai R. 2015. Frequency of Epstein-Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India. Indian J. Med. Microbiol. 33, 369–373.

    Article  PubMed  CAS  Google Scholar 

  11. Kayamba V., Monze M., Asombang A.W., Zyambo K., Kelly P. 2016. Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: A case-control study. Pan. Afr. Med. J. 23, 45.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Banko A.V., Lazarevic I.B., Folic M.M., Djukic V.B., Cirkovic A.M., Karalic D.Z., Cupic M.D., Jovanovic T.P. 2016. Characterization of the variability of Epstein- Barr virus genes in nasopharyngeal biopsies: Potential predictors for carcinoma progression. PLoS One. 11, e0153498.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Frappier L. 2015. EBNA1. Curr. Top. Microbiol. Immunol. 391, 3–34.

    PubMed  CAS  Google Scholar 

  14. Myhr K.M., Riise T., Barrett-Connor E., Myrmel H., Vedeler C., Grønning M., Kalvenes M.B., Nyland H. 1998. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: A population based case-control study from western Norway. Neurol. Neurosurg. Psychiatry. 64, 539–542.

    Article  CAS  Google Scholar 

  15. Lomakin Y., Arapidi G.P., Chernov A., Ziganshin R., Tcyganov E., Lyadova I., Butenko I.O., Osetrova M., Ponomarenko N., Telegin G, Govorun V.M., Gabibov A., Belogurov A., Jr. 2017. Exposure to the Epstein-Barr viral antigen latent membrane protein 1 induces myelinreactive antibodies in vivo. Front Immunol. 8, 777, 1–11.

    Google Scholar 

  16. Piroozmand A., Haddad Kashani H., Zamani B. 2017. Correlation between Epstein-Barr virus infection and disease activity of systemic lupus erythematosus: A cross-sectional study. Asian Pac. J. Cancer Prev. 18, 523–527.

    PubMed  PubMed Central  Google Scholar 

  17. Pan R., Liu X., Zhou S., Ning Z., Zheng H., Gao M., Ding Y., Yao W., Liao X., He N. 2017. Differential prevalence and correlates of whole blood Epstein-Barr virus DNA between HIV-positive and HIV-negative men who have sex with men in Shanghai, China. Epidemiol. Infect. 145, 2330–2340.

    Article  PubMed  CAS  Google Scholar 

  18. Lindsey J.W., de Gannes S.L., Pate K.A., Zhao X. 2016. Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L. Mol. Immunol. 69, 7–12.

    Article  PubMed  CAS  Google Scholar 

  19. Lindsey J.W. 2017. Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins. Neuroimmunology. 310, 131–134.

    Article  CAS  Google Scholar 

  20. Al Sidairi H., Binkhamis K., Jackson C., Roberts C., Heinstein C., MacDonald J., Needle R., Hatchette T.F., LeBlanc J.J. 2017. Comparison of two automated instruments for Epstein-Barr virus serology in a large adult hospital and implementation of an Epstein-Barr virus nuclear antigen-based testing algorithm. J. Med. Microbiol. 66 (11), 1628–1634. doi 10.1099/jmm.0.000616

    Article  PubMed  Google Scholar 

  21. Maylin S., Feghoul L., Salmona M., Herda A., Mercier-Delarue S., Simon F., Legoff J. 2017. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation. Med. Virol. 89, 2003–2010.

    Article  CAS  Google Scholar 

  22. Maerle A.V., Voronina D.V., Dobrochaeva K.L., Galanina O.E., Alekseev L.P., Bovin N.V., Zavriev S.K., Ryazantsev D.Y. 2017. Immuno-PCR technology for detection of natural human antibodies against Le(c) disaccharide. Glycoconj. J. 34 (32), 199–205.

    Article  PubMed  CAS  Google Scholar 

  23. Svirshchevskaya E., Fattakhova G., Khlgatian S., Chudakov D., Kashirina E., Ryazantsev D., Kotsareva O., Zavriev S. 2016. Direct versus sequential immunoglobulins switch in allergy and antiviral responses. Clin. Immunol. 170, 31–38.

    Article  PubMed  CAS  Google Scholar 

  24. Loebel M., Eckey M., Sotzny F., Hahn E., Bauer S., Grabowski P., Zerweck J., Holenya P., Hanitsch L.G., Wittke K., Borchmann P., Rüffer J.U., Hiepe F., Ruprecht K., Behrends U., et al. 2017. Serological profiling of the EBV immune response in chronic fatigue syndrome using a peptide microarray. PLoS One. 12, e0179124.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Simon K.C., Saghafian-Hedengren S., Sverremark-Ekström E., Nilsson C., Ascherio A. 2012. Age at Epstein-Barr virus infection and Epstein-Barr virus nuclear antigen-1 antibodies in Swedish children. Mult. Scler. Relat. Disord. 1 (3), 136–138.

    Article  PubMed  Google Scholar 

  26. Fachiroh J., Schouten T., Hariwiyanto B., Paramita D.K., Harijadi A., Haryana S.M., Ng M.H., Middeldorp J.M. 2004. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: A comparison of Indonesian, Chinese, and European subjects. J. Infect. Dis. 190, 53–62.

    Article  PubMed  CAS  Google Scholar 

  27. Nociti V., Frisullo G., Marti A., Luigetti M., Iorio R., Patanella A.K., Bianco A., Tonali P.A., Grillo R.L., Sabatelli M., Batocchi A.P. 2010. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. J. Neuroimmunol. 225, 149–152.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Svirshchevskaya.

Additional information

Original Russian Text © V.D. Pivovarov, D.Yu. Ryazantsev, M.A. Simonova, T.V. Yegorova, S.V. Khlgatian, S.K. Zavriev, E.V. Svirshchevskaya, 2018, published in Molekulyarnaya Biologiya, 2018, Vol. 52, No. 4, pp. 727–734.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pivovarov, V.D., Ryazantsev, D.Y., Simonova, M.A. et al. Immuno-PCR Assay for Quantitation of Antibodies to Epstein–Barr Virus. Mol Biol 52, 629–635 (2018). https://doi.org/10.1134/S0026893318040155

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893318040155

Keywords

Navigation